top of page

In the midst of talk of 2024, DeSantis leans into the COVID-19 treatment fight


Photo Credit: Gage Skidmore

In the midst of speculation about a possible presidential run in 2024, Florida Gov. Ron DeSantis (R) is launching a new front in his battle with President Biden over COVID-19 policies, this time over the administration's decision to restrict the use of two monoclonal antibody treatments for the virus.


Despite evidence that antibody treatments are ineffective against the omicron variant that is currently sweeping the country, DeSantis has increased his criticism of the decision in recent days, describing it as a form of "medical authoritarianism" that severely restricts the choices of those infected with COVID-19.


So far, the White House has ignored DeSantis' critique, emphasising the importance of immunizations and booster injections in combating the variation.


The struggle with the Biden administration over antibody therapies is the latest attempt by Florida Governor Ron DeSantis to carve himself a separate political lane ahead of a possible White House candidacy. DeSantis rose to prominence among conservatives as a vocal opponent of federal COVID-19 policy.


27 Jan 2022

 
 
 

Comments


Contact us

Letter to Editor-In-Chief
Editor@capitoltimesmedia.com

For Advertising in
Capitol Times Magazine:

ads@capitoltimesmedia.com

Capitol Times magazine Issue 5
Capitol times magazine 9
Capitol times magazine 10

Join our mailing list

FOLLOW US

  • X
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube

Disclaimer:

The views and opinions expressed in the articles or Interviews published in this magazine are solely those of the respective authors and do not necessarily reflect the official policy or position of the Capitol Times magazine or Capitol Times Media , its editors, or its staff. The authors are solely responsible for the content of their articles. The magazine strives to provide a platform for diverse voices and opinions, and we value the principle of free expression. The magazine assumes no responsibility or liability for any errors or omissions in the content of the articles. In no event shall the Capitol Times magazine or Capitol Times Media be liable for any special, direct, indirect, or incidental damages. Furthermore, the inclusion of advertisements or sponsored content in Capitol Times magazine does not constitute an endorsement or guarantee of the products, services, or views promoted by the advertisers. Readers are encouraged to conduct their own research and exercise caution when making decisions based on advertisements or sponsored content featured in this publication.

Thank you for reading and engaging with our publication. Your feedback is valuable to us as we continue to provide a platform for thought-provoking content and diverse perspectives.

© 2024 by Capitol Times Media LLC - Privacy Policy

bottom of page